Skip to main content

An official website of the United States government

You have 2 new alerts

Japanese Encephalitis Vaccine (JEV)

Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information

  • Contract Opportunity Type: Presolicitation (Original)
  • Original Published Date: Aug 12, 2024 12:50 pm EDT
  • Original Response Date: Aug 28, 2024 11:59 pm EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Sep 12, 2024
  • Initiative:
    • None

Classification

  • Original Set Aside:
  • Product Service Code:
  • NAICS Code:
  • Place of Performance:
    Philadelphia , PA 19111
    USA

Description

Solicitation: SPE2DP-24-R-0002

Item: Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV)

NSN: 6505-01-607-7018

Description:

The Defense Logistics Agency Troop Support has a requirement for the supply of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV). JEV shall be made in accordance with MPID Number 4 dated 30 January 2020, which is attached to this notice.

The Solicitation will be issued under authority 10 U.S.C. 2304(c)(1), only one responsible source.

The Government intends to use Part 12 for this acquisition – per FAR 10.002(d)(2).

The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract.  The contract will consist of a one-year base term.  The minimum quantity is 200,060 EA. The estimated quantity is 208,320 EA. The maximum quantity is 300,300 EA.

Inspection/Acceptance at Destination

FOB Destination

Delivery Destination:

DODAAC: SV3100

DLA Distribution Susquehanna

U Avenue, Bldg. 89, Door 6

New Cumberland, PA 17070

Attn: Jim Earp

Production Lead Time is 120 days after issuance date of the delivery order (DD1155).

All responsible sources may submit a proposal and shall be considered by the Agency.

The successful contractor shall have FDA approval to sell JEV before award decision.

****************************************************************************

IMPORTANT NOTICES

Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form.   Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/.  Once the solicitation is posted, it will be available for viewing on DIBBS.  From the DIBBS homepage, select "Solicitations" from the top bar to search for the solicitation. DIBBS Help can be accessed from the DIBBS homepage. Interested parties are further advised to set up automated notifications of solicitation changes through this website. Solicitation SPE2DP-23-R-0002 is expected to be issued on or around May 2024. 

******************************************************************************
 

Contact Information

Primary Point of Contact

Secondary Point of Contact





History